![](/img/cover-not-exists.png)
520 Efficacy of Ibodutant, a Selective Antagonist of Neurokinin 2 Receptors, in Irritable Bowel Syndrome With Diarrhoea (IBS-D): The Results of a Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Phase II Study (the IRIS-2)
Tack, Jan F., Dochev, Yavor S., Bochenek, Anna, Atanasov, Ivan, Horynski, Marek, Lundqvist, Pernille, Schumacher, Kai, Otranto, Isabella, Capriati, Angela, Maggi, Carlo AlbertoVolume:
144
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(13)60340-6
Date:
May, 2013
File:
PDF, 639 KB
english, 2013